These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7360842

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phenylethylaminergic mechanisms in attention-deficit disorder.
    Baker GB, Bornstein RA, Rouget AC, Ashton SE, van Muyden JC, Coutts RT.
    Biol Psychiatry; 1991 Jan 01; 29(1):15-22. PubMed ID: 2001444
    [Abstract] [Full Text] [Related]

  • 8. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H, Reynolds GP, Sandler M, Waldmeier P, Lauber J, Riederer P, Gattaz WF.
    Arch Psychiatr Nervenkr (1970); 1983 Jan 01; 232(6):463-71. PubMed ID: 6134517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beta-phenylethylamine in human urine.
    Fischer E, Heller B, Miró AH.
    Arzneimittelforschung; 1968 Nov 01; 18(11):1486. PubMed ID: 5755919
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phenylethylamine in paranoid chronic schizophrenia.
    Potkin SG, Karoum F, Chuang LW, Cannon-Spoor HE, Phillips I, Wyatt RJ.
    Science; 1979 Oct 26; 206(4417):470-1. PubMed ID: 504988
    [Abstract] [Full Text] [Related]

  • 13. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia.
    Jeste DV, Doongaji DR, Panjwani D, Datta M, Potkin SG, Karoum F, Thatte S, Sheth AS, Apte JS, Wyatt RJ.
    Psychiatry Res; 1981 Dec 26; 5(3):341-52. PubMed ID: 6948314
    [Abstract] [Full Text] [Related]

  • 14. [Platelet serotonin in endogenous depressive patients and normal controls].
    Spatz H, Spatz N.
    Acta Psiquiatr Psicol Am Lat; 1995 Sep 26; 41(3):230-6. PubMed ID: 8728799
    [Abstract] [Full Text] [Related]

  • 15. Failure to detect p-methoxyphenylethylamine derivatives in human urine.
    Jones RL, Bory P, Brown WT, McGeer PL.
    Can J Biochem; 1969 Feb 26; 47(2):185-95. PubMed ID: 5774808
    [No Abstract] [Full Text] [Related]

  • 16. [Significance and identification of 3,4-dimethoxyphenylethylamine in the urine of schizophrenic patients (pink spot reaction)].
    Stanciu E, Csiky K, Rácz E.
    Neurol Psihiatr Neurochir; 1971 Feb 26; 16(4):305-12. PubMed ID: 5118389
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A fluorometric assay for beta-phenylethylamine in human urine.
    Suzuki O, Yagi K.
    Clin Chim Acta; 1977 Aug 01; 78(3):401-10. PubMed ID: 884865
    [Abstract] [Full Text] [Related]

  • 19. Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia?
    Sandler M, Ruthven CR, Goodwin BL, King GS, Pettit BR, Reynolds GP, Tyrer SP, Weller MP, Hirsch SR.
    Commun Psychopharmacol; 1978 Aug 01; 2(3):199-202. PubMed ID: 699534
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.